Fu, Yang-Xin
The University of Texas Southwestern Medical Center
25 papers on CoChatORCID 0000-0001-8441-6617
Most cited papers
- Verified
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 4,148
- Verified
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity
interferon and immune responsesImmunotherapy and Immune Responses
Cited by 2,182
- Verified
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1,324
- Verified
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
He, Y., Fu, L., Li, Y., Wang, W., Gong, M., Zhang, J., Dong, X., Huang, J., Wang, Q., Mackay, C. R., et al. (2021) · Cell Metabolism
Gut microbiota and healthCancer Immunotherapy and Biomarkers
Cited by 729
- Verified
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity
Park, S., Jiang, Z., Mortenson, E. D., Deng, L., Radkevich-Brown, O., Yang, X., Sattar, H., Wang, Y., Brown, N. K., Greene, M., et al. (2010) · Cancer Cell
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research
Cited by 577
- Verified
PD‐L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
Peng, Q., Qiu, X., Zhang, Z., Zhang, S., Zhang, Y., Liang, Y., Guo, J., Peng, H., Chen, M., Fu, Y.-X., et al. (2020) · Nature Communications
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 553
- Verified
Type I interferon response and innate immune sensing of cancer
Fuertes, M. B., Woo, S.-R., Burnett, B., Fu, Y.-X., & Gajewski, T. F. (2013) · Trends in Immunology
interferon and immune responsesImmunotherapy and Immune Responses
Cited by 375
- Verified
Adaptive immune cells temper initial innate responses
Dong Kim, K., Zhao, J., Auh, S., Yang, X., Du, P., Tang, H., & Fu, Y.-X. (2007) · Nature Medicine
Immune Response and InflammationT-cell and B-cell Immunology
Cited by 348
- Verified
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
Deng, M., Gui, X., Kim, J., Xie, L., Chen, W., Li, Z., He, L., Chen, Y., Chen, H., Luo, W., et al. (2018) · Nature
Immune Cell Function and InteractionCancer Immunotherapy and Biomarkers
Cited by 305
- Verified
Tumor-infiltrating T lymphocytes: Friends or foes?
Yu, P., & Fu, Y.-X. (2006) · Laboratory Investigation
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 299
- Verified
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity
Lu, C., Guan, J., Lu, S., Jin, Q., Rousseau, B., Lu, T., Stephens, D., Zhang, H., Zhu, J., Yang, M., et al. (2021) · Cancer Cell
Cancer Immunotherapy and Biomarkersinterferon and immune responses
Cited by 285
- Verified
The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy
Wang, G.-Z., Zhang, L., Zhao, X.-C., Gao, S.-H., Qu, L.-W., Yu, H., Fang, W.-F., Zhou, Y.-C., Liang, F., Zhang, C., et al. (2019) · Nature Communications
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 213
- Verified
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
Sun, Z., Ren, Z., Yang, K., Liu, Z., Cao, S., Deng, S., Xu, L., Liang, Y., Guo, J., Bian, Y., et al. (2019) · Nature Communications
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 211
- VerifiedRetracted
Targeting CD137 enhances the efficacy of cetuximab
Kohrt, H. E., Colevas, A. D., Houot, R., Weiskopf, K., Goldstein, M. J., Lund, P., Mueller, A., Sagiv-Barfi, I., Marabelle, A., Lira, R., et al. (2014) · Journal of Clinical Investigation
Immune Cell Function and InteractionMonoclonal and Polyclonal Antibodies Research
Cited by 160
- Verified
Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota
Guo, X., Liang, Y., Zhang, Y., Lasorella, A., Kee, B. L., & Fu, Y.-X. (2015) · Immunity
IL-33, ST2, and ILC PathwaysGut microbiota and health
Cited by 138
- Verified
AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells
Li, H., Liu, Z., Liu, L., Zhang, H., Han, C., Girard, L., Park, H., Zhang, A., Dong, C., Ye, J., et al. (2022) · Cell Reports Medicine
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 102
- Verified
Macrophage-derived IL-1α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity
Zhang, C., Feng, J., Du, J., Zhuo, Z., Yang, S., Zhang, W., Wang, W., Zhang, S., Iwakura, Y., Meng, G., et al. (2018) · Cellular & Molecular Immunology
Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology
Cited by 99
- Verified
Type I IFN activating type I dendritic cells for antitumor immunity
Liang, Y., Hannan, R., & Fu, Y.-X. (2021) · Clinical Cancer Research
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 91
- Verified
T cell-derived lymphotoxin regulates liver regeneration
Tumanov, A. V., Koroleva, E. P., Christiansen, P. A., Khan, M. A., Ruddy, M. J., Burnette, B., Papa, S., Franzoso, G., Nedospasov, S. A., Fu, Y., et al. (2009) · Gastroenterology
Liver physiology and pathologyOrgan Transplantation Techniques and Outcomes
Cited by 89
- Verified
Effective anti-neu-initiated antitumor responses require the complex role of CD4+ T cells
Mortenson, E. D., Park, S., Jiang, Z., Wang, S., & Fu, Y.-X. (2013) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 66
- Verified
B and T Lymphocyte Attenuator Tempers Early Infection Immunity
Sun, Y., Brown, N. K., Ruddy, M. J., Miller, M. L., Lee, Y., Wang, Y., Murphy, K. M., Pfeffer, K., Chen, L., Kaye, J., et al. (2009) · The Journal of Immunology
T-cell and B-cell ImmunologyImmune Response and Inflammation
Cited by 51
- Verified
Lymphotoxin β Receptor (LtβR): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using LtβR–Ig Protein
Plant, S. R., Iocca, H. A., Wang, Y., Thrash, J. C., O'Connor, B. P., Arnett, H. A., Fu, Y.-X., Carson, M. J., & Ting, J. P.-Y. (2007) · The Journal of Neuroscience
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 51
- Verified
B and T Lymphocyte Attenuator Down-regulation by HIV-1 Depends on Type I Interferon and Contributes to T-Cell Hyperactivation
Zhang, Z., Xu, X., Lu, J., Zhang, S., Gu, L., Fu, J., Jin, L., Li, H., Zhao, M., Zhang, J., et al. (2011) · The Journal of Infectious Diseases
HIV Research and TreatmentT-cell and B-cell Immunology
Cited by 35
- Verified
Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth
Zheng, H., Zou, W., Shen, J., Xu, L., Wang, S., Fu, Y.-X., & Fan, W. (2016) · Stem Cells Translational Medicine
Mesenchymal stem cell researchImmune cells in cancer
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free